1Butler GS,Will H, Atkinson SJ,et al.Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue of metallop roteinaae.Eur J Biochem,1997,244(2):653-657.
2Zhang J,Hampton AL,Nie G,et al.Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type-1 MMP:Enzymes coordinately expressed in human endometrium.Biol Reprod,2000,62( 1 ):85 -94.
3Schatz F, Krikun G,Runic R,et al.Imphcations of decidualization-associated protease expression in implantation and menstruation.Semin Reprod Endocrinol,1999,17(l): 3-12.
4Chou CS, Tai CJ, MacCalman CD,et al.Dose-dependent effects of gonadotropin releasing hormone on matrix metalloproteinase (MMP)-2, and MMP-9 and tissue specific inhibitor of metalloproteinases-1 messenger ribonucleic acid levels in human decidual Stromal cellsin vitro. J Clin Endocrinol Metab, 2003, 88(2):680-688.
5Hirata M, Sato T, Tsumagari M, et al.Differential Regulation of the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases by Cytokines and Growth Factors in Bovine Endometrial Stromal Cells and Trophoblast Cell Line BT-1 In Vitro Biol Reprod ,2003,68(4): 1276-1281.
6Kim JH,Hong SH,Nah HY,et al.Influence of transforming growth factor-alpha on expression of matrix metalloproteinase-2,matrix metalloproteinase-9,and epidermal growth factor receptor in the mouse blastocvsts.J Assist Reprod Genet,2002,19(5): 232-239.
7Salamonsen LA,Lathbury IJ.Endometrial leukocytes and menstruation.Hum Reprod Uodate,2000,6(1):16-27.
8Salamonsen LA,Zhang J,Hampton A.Regulation of matrix metalloproteinases in human endometrium.Hum Reprod,2000,15 [Suppl 3]:112-119.
9Novaro V,Colman-lemer A,Ortega FV,et al.Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture.Reprod Fertil Dev,2001,13(5-6):411-420.
10Novaro V,Pustovrh C,Colman-Lemer A,et al.Nitric oxide induces gelatinase A (m-atrix metalloproteinase 2) during rat embryo implantation. Fertil Steril, 2002, 78(6): 1278-1287.
4Lain KY, Roberts JM. Contemporary concepts of the patho genesis and management of preeclampsia. JAMA, 2002, 287 (24) : 3183-3186.
5Gallegos NC, Smales C, Savage FJ, et al. The distribution of matrix metalloproteinases and tissue inhibitor of metalloprotei- nases in coloreetal cancer. Surg Oncol, 1995,4 : 21-29.
6Bulen EC, Longaker TM, Updike DI: Tissue inhibitor of metalloproteinases-1 is decreaced and activated gelatinases are increased in chronic wounds. J Invest Dermatol, 1995, 104: 236-240.
7Laird SM. Metalloproteinases and tissue inhibitor of metallo- proteinase-1 (TIMP-1) in endometrial flushlngs from pre and postmenopausal women and from women with endometrial ad- enocarcinoma. J Reprod Fertil, 1999,115 : 225-232.
8Lyall F, Simpson H,Bulmer JN, et al. Transforming growth factor-bate expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol, 2001, 159(5): 1827-1838.
9Naicker T, Khedun SM, Moodley J, et al. Quantitative analy- sis of trophoblast invasion in preeclampsia [J] . Acta Obstet Gynecol Scand, 2003, 82 (8) : 722 - 729.
10Riley SC, Leask R, Denison FC, et al. Secretion of matrix metalloproteinase - 2, matrix metalloproteinase - 9 and tissue inhibitor of metalloproteinases into the intrauterine compart- ments during early pregnancy (J3 . Mol Hum Reprod, 1999, 5 (4): 376-381.
